July 2026 · Accountability
Best Of
This page contains affiliate links. We may earn a commission at no extra cost to you — it never influences our rankings. See full disclosure below.

Post-Study Accountability Rankings: Who Passed the Yale Secret Shopper Test

Compare GLP-1 Editorial Team

The July 2026 Yale secret shopper study found 45 of 49 telehealth GLP-1 platforms prescribed with minimal clinical oversight. We applied that same lens to the providers we track. Here's how it changes our rankings.

What the study actually measured

Researchers posing as patients evaluated how thoroughly each platform reviewed intake before prescribing — specifically whether a licensed clinician provided genuine, individualized review versus largely automated approval.

How we're incorporating this into our scoring

Clinical oversight was already part of our methodology, but this study gives us a sharper, externally validated benchmark to apply it against. Providers with documented, individualized clinical review score meaningfully higher in our updated rankings than those relying on automated approval alone.

Embody From $149

Documented clinical review as part of standard process.

Visit Embody →

Sesame Care From $149

A wide network of licensed physicians providing individualized evaluation.

Prescribes FDA-approved brand-name medication only. Not a compounded provider.
Visit Sesame Care →

What to ask any provider directly

Regardless of what any ranking says, you can verify this yourself: ask whether a licensed clinician will individually review your specific answers, or whether approval happens automatically off the questionnaire. A provider's answer to that single question tells you more than most marketing copy will.

Ad Disclosure: We earn commission from featured providers. This never affects our rankings, which follow our published methodology. Medical Disclaimer: Informational only, not medical advice. Consult a licensed provider. Compounded medications are not FDA-approved.